BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 9338481)

  • 1. Current issues in the treatment and prophylaxis of Pneumocystis carinii pneumonia in HIV infection.
    Morris-Jones SD; Easterbrook PJ
    J Antimicrob Chemother; 1997 Sep; 40(3):315-8. PubMed ID: 9338481
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinical efficacy of first- and second-line treatments for HIV-associated Pneumocystis jirovecii pneumonia: a tri-centre cohort study.
    Helweg-Larsen J; Benfield T; Atzori C; Miller RF
    J Antimicrob Chemother; 2009 Dec; 64(6):1282-90. PubMed ID: 19858161
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Therapy and prevention of pneumocystis carinii pneumonia].
    Goebel FD; Bogner JR
    Internist (Berl); 1995 Dec; 36(12):1150-5. PubMed ID: 8567220
    [No Abstract]   [Full Text] [Related]  

  • 4. Prophylaxis and therapy for Pneumocystis pneumonia--where are we?
    Masur H
    Infect Agents Dis; 1992 Oct; 1(5):270-8. PubMed ID: 1344666
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of three regimens for treatment of mild to moderate Pneumocystis carinii pneumonia in patients with AIDS. A double-blind, randomized, trial of oral trimethoprim-sulfamethoxazole, dapsone-trimethoprim, and clindamycin-primaquine. ACTG 108 Study Group.
    Safrin S; Finkelstein DM; Feinberg J; Frame P; Simpson G; Wu A; Cheung T; Soeiro R; Hojczyk P; Black JR
    Ann Intern Med; 1996 May; 124(9):792-802. PubMed ID: 8610948
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Options in the management of pneumonia caused by Pneumocystis carinii in patients with acquired immune deficiency syndrome and intolerance to trimethoprim/sulfamethoxazole.
    Korraa H; Saadeh C
    South Med J; 1996 Mar; 89(3):272-7. PubMed ID: 8604455
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevention and treatment of Pneumocystis carinii pneumonia in patients infected with HIV.
    Drug Ther Bull; 1994 Feb; 32(2):12-5. PubMed ID: 7654282
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reasons for failure of prophylaxis for Pneumocystis carinii pneumonia.
    Edge MD; Rimland D
    AIDS; 1999 May; 13(8):991-2. PubMed ID: 10371182
    [No Abstract]   [Full Text] [Related]  

  • 9. Failure of pentamidine as prophylaxis for Pneumocystis carinii pneumonia in HIV-infected children.
    Schuval SJ; Bonagura VR
    Arch Pediatr Adolesc Med; 1994 Aug; 148(8):876-9. PubMed ID: 8044270
    [No Abstract]   [Full Text] [Related]  

  • 10. A meta-analysis of salvage therapy for Pneumocystis carinii pneumonia.
    Smego RA; Nagar S; Maloba B; Popara M
    Arch Intern Med; 2001 Jun; 161(12):1529-33. PubMed ID: 11427101
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of clindamycin/primaquine versus trimethoprim/sulfamethoxazole in primary treatment of Pneumocystis carinii pneumonia.
    Ruf B; Rohde I; Pohle HD
    Eur J Clin Microbiol Infect Dis; 1991 Mar; 10(3):207-10. PubMed ID: 2060533
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clindamycin/primaquine versus trimethoprim-sulfamethoxazole as primary therapy for Pneumocystis carinii pneumonia in AIDS: a randomized, double-blind pilot trial.
    Toma E; Fournier S; Dumont M; Bolduc P; Deschamps H
    Clin Infect Dis; 1993 Aug; 17(2):178-84. PubMed ID: 8399863
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Second-line salvage treatment of AIDS-associated Pneumocystis jirovecii pneumonia: a case series and systematic review.
    Benfield T; Atzori C; Miller RF; Helweg-Larsen J
    J Acquir Immune Defic Syndr; 2008 May; 48(1):63-7. PubMed ID: 18360286
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clindamycin with primaquine vs. Trimethoprim-sulfamethoxazole therapy for mild and moderately severe Pneumocystis carinii pneumonia in patients with AIDS: a multicenter, double-blind, randomized trial (CTN 004). CTN-PCP Study Group.
    Toma E; Thorne A; Singer J; Raboud J; Lemieux C; Trottier S; Bergeron MG; Tsoukas C; Falutz J; Lalonde R; Gaudreau C; Therrien R
    Clin Infect Dis; 1998 Sep; 27(3):524-30. PubMed ID: 9770152
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aerosolized pentamidine prophylaxis of Pneumocystis carinii pneumonia.
    Wilkinson SB
    Am J Med; 1995 Apr; 98(4):422-3. PubMed ID: 7709963
    [No Abstract]   [Full Text] [Related]  

  • 16. Dilemmas in the prophylaxis of Pneumocystis carinii pneumonia.
    Glatt AE
    South Med J; 1994 Apr; 87(4):429-30. PubMed ID: 8153765
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intravenous pentamidine as an alternate for Pneumocystis carinii pneumonia prophylaxis in children with HIV infection.
    Gupta M; Stephenson K; Gauar S; Frenkel L
    Pediatr Pulmonol Suppl; 1997; 16():199-200. PubMed ID: 9443273
    [No Abstract]   [Full Text] [Related]  

  • 18. A difficult case of PCP.
    Zuger A
    AIDS Clin Care; 1995 Sep; 7(9):74, 78. PubMed ID: 11362780
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Failure of intravenous pentamidine prophylaxis for Pneumocystis carinii pneumonia.
    Weintrub PS; Wara DW; Duliege AM
    J Pediatr; 1993 Jan; 122(1):163-4. PubMed ID: 8419606
    [No Abstract]   [Full Text] [Related]  

  • 20. The effect of Pneumocystis carinii pneumonia prophylaxis regimens on the incidence of bacterial infections in HIV-infected patients.
    Mayer HB; Rose DN; Cohen S; Gurtman AC; Cheung TW; Szabo S
    AIDS; 1993 Dec; 7(12):1687-9. PubMed ID: 8286088
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.